Table 1

Patient characteristics by SPC referral

Total
n (%)
No SPC referral
n (%)
SPC referral
n (%)
OR (95% CI)
Total323 (100)168 (100)155 (100)
Sex
 Male178 (55.1)92 (54.8)86 (55.5)1
 Female145 (44.9)76 (45.2)69 (44.5)0.97 (0.63 to 1.51)
Age, years
 ≤6058 (18.0)28 (16.7)30 (19.3)1
 61–74122 (37.8)61 (36.3)61 (39.4)0.93 (0.50 to 1.74)
 75+143 (44.2)79 (47.0)64 (41.3)0.76 (0.41 to 1.34)
Diagnosis
 AML107 (33.1)61 (36.3)46 (29.7)1
 DLBCL102 (31.6)61 (36.3)41 (26.4)0.89 (0.51 to 1.55)
 Myeloma114 (35.3)46 (27.4)68 (43.9)1.96 (1.15 to 3.35)
Time from diagnosis to death (months)
 ≤175 (23.2)59 (35.1)16 (10.3)1
 1–683 (25.7)47 (28.0)36 (23.2)2.82 (1.40 to 5.70)
 6–1262 (19.2)25 (14.9)37 (23.9)5.46 (2.58 to 11.56)
 12+103 (31.9)37 (22.0)66 (42.6)6.58 (3.32 to 13.03)
Place of death
 Hospital240 (74.3)138 (82.1)102 (65.8)1
 Home49 (15.2)15 (8.9)34 (21.9)3.07 (1.59 to 5.93)
 Hospice18 (5.6)4 (2.4)14 (9.0)4.74 (1.51 to 14.81)
 Nursing home16 (4.9)11 (6.6)5 (3.2)0.62 (0.21 to 1.83)
  • AML, acute myeloid leukaemia; DLBCL, diffuse large B-cell lymphoma; SPC, specialist palliative care.